The Download: generative AI therapy, and the future of 23andMe’s genetic data
This newsletter covers the intersection of technology with health, privacy, and society, highlighting both potential benefits and emerging challenges. It focuses on the impact of AI on mental health, genetic data privacy concerns, and broader trends in technology and their societal consequences.
-
AI in Healthcare: The efficacy of generative AI in therapy is being explored, while also cautioning against unregulated deployment.
-
Data Privacy: The potential sale of 23andMe's genetic data raises significant privacy concerns, emphasizing the need for judicial intervention.
-
Surveillance: Cities are increasing surveillance, raising concerns from citizens and activists.
-
Measles Outbreak: The US is dealing with a preventable measles outbreak due to lowered vaccination rates, causing the government to hide the information.
-
A clinical trial suggests generative AI therapy can be as effective as human therapy for mental health issues, prompting ethical and regulatory discussions.
-
A bankruptcy judge holds significant power over the future of millions of users' genetic data held by 23andMe.
-
China's air pollution cleanup efforts paradoxically contribute to global warming, revealing the complexity of climate change mitigation.
-
Brands are cautiously spending on X (formerly Twitter) to avoid negative attention from Elon Musk.